PuSH - Publication Server of Helmholtz Zentrum München

259 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Artunc, F. et al.: Performance of a novel high sensitivity cardiac troponin i assay in asymptomatic hemodialysis patients - evidence for sex-specific differences. Clin. Chem. Lab. Med., accepted (2019)
2.
Gerst, F. et al.: Glucose responsiveness of β-cells depends on fatty acids. Exp. Clin. Endocrinol. Diabet., accepted (2019)
3.
Gerst, F. et al.: What role do fat cells play in pancreatic tissue? Mol. Metab., accepted (2019)
4.
Graae, A.S.* et al.: ADAMTS9 regulates skeletal muscle insulin sensitivity through extracellular matrix alterations. Diabetes 68, 502-514 (2019)
5.
Hulman, A.* et al.: Glucose measurements at various time points during the OGTT and their role in capturing glucose response patterns. Diabetes Care 42, e56-e57 (2019)
6.
Jaghutriz, B.A. et al.: Gene x gene interactions highlight the role of incretin resistance for insulin secretion. Front. Endocrin. 10:72 (2019)
7.
Jaghutriz, B.A. et al.: Metabolomic characteristics of fatty pancreas. Exp. Clin. Endocrinol. Diabet., accepted (2019)
8.
Ji, Y.* et al.: Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 68, 207-219 (2019)
9.
Kempe-Teufel, D. et al.: A polygenic risk score of lipolysis-increasing alleles determines visceral fat mass and proinsulin conversion. J. Clin. Endocrinol. Metab. 104, 1090-1098 (2019)
10.
Keuper, M. et al.: Preadipocytes of obese humans display gender-specific bioenergetic responses to glucose and insulin. Mol. Metab. 20, 28-37 (2019)
11.
Keuper, M. ; Häring, H.-U. & Staiger, H.: Circulating FGF21 levels in human health and metabolic disease. Exp. Clin. Endocrinol. Diabet., accepted (2019)
12.
Linder, K. et al.: Dietary niacin intake predicts the decrease of liver fat content during a lifestyle intervention. Sci. Rep. 9:1303 (2019)
13.
Lutz, S.Z. et al.: The Gly385(388)arg polymorphism of the FGFR4 receptor regulates hepatic lipogenesis under healthy diet. J. Clin. Endocrinol. Metab. 104, 2041-2053 (2019)
14.
Lutz, S.Z. et al.: Sex-specific associations of testosterone with metabolic traits. Front. Endocrin. 10:90 (2019)
15.
Plomgaard, P.* et al.: Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels. Diabetes Obes. Metab. 21, 993-1000 (2019)
16.
Schork, A. et al.: Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: A prospective study using bioimpedance spectroscopy. Cardiovasc. Diabetol. 18:46 (2019)
17.
Valenta, V. et al.: Risikokommunikation und Inanspruchnahme von Präventionsangeboten des Diabetes mellitus Typ 2 mithilfe des Deutschen Diabetes-Risiko-Tests. Diabetol. Stoffwechs. 14, 132-138 (2019)
18.
Wang, X. et al.: Point mutations in the PDX1 transactivation domain impair human β-cell development and function. Mol. Metab. 24, 80-97 (2019)
19.
Willmann, C. et al.: Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: A randomized and controlled dietary intervention study. Am. J. Clin. Nutr. 109, 288-296 (2019)
20.
Babbar, R.* et al.: Prediction of glucose tolerance without an oral glucose tolerance test. Front. Endocrin. 9:82 (2018)